Use este identificador para citar ou linkar para este item: https://ri.ufs.br/jspui/handle/riufs/23838
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorMartins Filho, Paulo Ricardo Saquete-
dc.contributor.authorKameo, Simone Yuriko-
dc.contributor.authorMascarenhas‑Oliveira, Ana Carolina-
dc.contributor.authorVieira, Nivaldo Farias-
dc.contributor.authorPeixoto, André Luis de Santana-
dc.date.accessioned2025-11-12T17:29:53Z-
dc.date.available2025-11-12T17:29:53Z-
dc.date.issued2013-04-
dc.identifier.citationMARTINS FILHO, P. R. S. et al. Panitumumab‑induced acneiform rash in a patient with metastatic colon adenocarcinoma. Indian Journal of Dermatology, Mumbai, v. 58, n. 2, mar./abr. 2013. Disponível em: https://journals.lww.com/ijd/fulltext/2013/58020/panitumumab_induced_acneiform_rash_in_a_patient.62.aspx. Acesso em: 12 nov. 2025.pt_BR
dc.identifier.issn1998-3611-
dc.identifier.urihttps://ri.ufs.br/jspui/handle/riufs/23838-
dc.languageengpt_BR
dc.publisherMedknow Publicationspt_BR
dc.relation.ispartofIndian Journal of Dermatologypt_BR
dc.subjectPanitumumab-induced acneiform rasheng
dc.subjectChemotherapeutic regimenseng
dc.subjectMetastatic colon adenocarcinomaeng
dc.subjectDermatologyeng
dc.titlePanitumumab‑induced acneiform rash in a patient with metastatic colon adenocarcinomapt_BR
dc.typeArtigopt_BR
dc.identifier.licenseCreative Commons Atribuição-NãoComercial-CompartilhaIgual 4.0 Internacional (CC BY-NC-SA 4.0)pt_BR
dc.description.resumoHuman epidermal growth factor receptor (HER1/EGFR) is a transmembrane glycoprotein of the tyrosine kinase growth factor family that is dysregulated in many solid tumors and correlated with increased metastasis, reduced survival, and poor prognosis. Panitumumab is a fully human immunoglobulin G2 monoclonal antibody that binds specifically to the EGFR with promising results for the treatment of metastatic colorectal cancer when used as monotherapy or when added to standard chemotherapeutic regimens. Despite the favorable toxicity and safety profiles, several adverse events have been reported, including gastrointestinal disorders, metabolism and nutritional disorders, and mild to moderate dermatologic toxicities. In this correspondence, we describe a case of panitumumab-induced acneiform rash in a patient with metastatic colon adenocarcinoma.pt_BR
dc.description.localMumbaipt_BR
Aparece nas coleções:DESL - Artigos de periódicos

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
PanitumumabInducedAcneiformRash.pdf694,25 kBAdobe PDFThumbnail
Visualizar/Abrir


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.